Paradoxically, being dead wrong assuming that TEVA's Lovenox will be approved, made me take profits from my MNTA position back then. So, Teva's BS wasn't all that bad from my point of view
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.